Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections
Venous Reflux, Venous Insufficiency, Venous Ulcer
About this trial
This is an interventional treatment trial for Venous Reflux focused on measuring Sclerotherapy, Venous Ablation, Reflux, Insufficiency, Ulcer
Eligibility Criteria
Inclusion Criteria: Patients who have saphenous vein reflux and a single venous ulcer of any size Exclusion Criteria: Patients with multiple venous ulcers
Sites / Locations
- Jobst Vascular Institute, ProMedica Toledo HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Arm 1: Combination Sclerotherapy & Ablation
Arm 2: Sclerotherapy Only
Standard Practice: Arm 1 will be patients receiving sclerotherapy and ablation at the start of treatment along with compression therapy. The patients in arm 1 will not receive any further treatment during the duration of the study.
Experimental Timeline: Arm 2 will be patients who receive sclerotherapy at the start of treatment along with compression therapy, and ablation 3 months later. All patients in arm 2 will receive ablation at their 3 month appointment. After ablation, the patients in arm 2 will not receive any further treatment for the remainder of the study.